Korean Pharmaceutical Association Urges People Not To Panic Over Iodide Products
This article was originally published in PharmAsia News
Executive Summary
SEOUL - To cope with rising requests for potassium iodide, the Korean Pharmaceutical Association has issued an appeal to the public, asking people not to panic about feared radiation exposure from Japan's earthquake-damaged nuclear power plants
You may also be interested in...
Korea Begins To Assess Public Health, Industry Fallout From Japan Disaster
SEOUL - While a growing number of countries such as the U.S., Italy, France, Australia, New Zealand, Britain, China, India and Kyrgyzstan are urging their nationals in Japan to evacuate, South Korea on Thursday started checking radiation levels of people coming into the country from Japan
FDA's Hamburg Says Japanese Crisis Shows Need To Fund Countermeasure Development
When Senators ask whether the U.S. is prepared for a nuclear disaster similar to one following the Japanese earthquake, FDA chief touts agency program that could help develop radiation treatments.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).